CS419991A3 - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
CS419991A3
CS419991A3 CS914199A CS419991A CS419991A3 CS 419991 A3 CS419991 A3 CS 419991A3 CS 914199 A CS914199 A CS 914199A CS 419991 A CS419991 A CS 419991A CS 419991 A3 CS419991 A3 CS 419991A3
Authority
CS
Czechoslovakia
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
CS914199A
Other languages
English (en)
Inventor
Fritz Dr Topfmeier
Gustav Dr Lettenbauer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CS419991A3 publication Critical patent/CS419991A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS914199A 1985-08-17 1991-12-31 Pharmaceutical preparations CS419991A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853529529 DE3529529A1 (de) 1985-08-17 1985-08-17 Verfahren zur herstellung einer stabilen modifikation von torasemid

Publications (1)

Publication Number Publication Date
CS419991A3 true CS419991A3 (en) 1992-06-17

Family

ID=6278766

Family Applications (2)

Application Number Title Priority Date Filing Date
CS865945A CS259891B2 (en) 1985-08-17 1986-08-11 Method of crystalline thorasemide preparation in pure modification i
CS914199A CS419991A3 (en) 1985-08-17 1991-12-31 Pharmaceutical preparations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS865945A CS259891B2 (en) 1985-08-17 1986-08-11 Method of crystalline thorasemide preparation in pure modification i

Country Status (25)

Country Link
US (4) US4743693A (cs)
EP (1) EP0212537B1 (cs)
JP (2) JPS6245576A (cs)
KR (1) KR930009818B1 (cs)
AU (1) AU573454B2 (cs)
CA (1) CA1307277C (cs)
CS (2) CS259891B2 (cs)
DD (1) DD259858A5 (cs)
DE (2) DE3529529A1 (cs)
DK (1) DK162518C (cs)
ES (1) ES2001522A6 (cs)
FI (1) FI82189C (cs)
GR (1) GR862139B (cs)
HK (1) HK59994A (cs)
HU (1) HU195778B (cs)
IE (1) IE59237B1 (cs)
IL (1) IL79672A (cs)
LT (1) LT3596B (cs)
NO (1) NO170079C (cs)
NZ (1) NZ217172A (cs)
PL (1) PL146086B1 (cs)
PT (1) PT83186B (cs)
SU (1) SU1480766A3 (cs)
UA (1) UA7080A1 (cs)
ZA (1) ZA866151B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
TW257757B (cs) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US6166045A (en) 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
IL148031A0 (en) 1999-08-11 2002-09-12 Teva Pharma Torsemide polymorphs
JP2004522780A (ja) * 2000-02-17 2004-07-29 テバ ファーマシューティカル インダストリーズ リミティド トルセミド・モディフィケーションiiを含む安定な医薬品製剤
CN1203059C (zh) 2000-03-20 2005-05-25 特瓦制药工业有限公司 新的制备托拉塞米中间体的方法
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
HRP20000765A2 (en) * 2000-11-10 2002-06-30 Pliva D D Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (cs) * 2001-08-03 2004-03-06 Ranbaxy Lab
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
WO2004046135A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
US7678816B2 (en) * 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
US10178893B1 (en) * 2013-06-14 2019-01-15 Scott Bradley Baker Shoe
FR3018688A1 (fr) * 2014-03-19 2015-09-25 Virbac Utilisation de torasemide a faible dose dans une composition veterinaire
US12048677B2 (en) 2014-12-12 2024-07-30 Ceva Sante Animale Compositions and uses thereof for the treatment of heart failure in domestic animals
EP3031471A1 (en) * 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals
EP3173075B1 (en) * 2015-11-27 2018-09-26 ACCUPHARMA Spolka z ograniczona odpowiedzialnoscia Pharmaceutical combination preparation of ace inhibitor and loop diuretic
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation

Also Published As

Publication number Publication date
NO170079B (no) 1992-06-01
IL79672A0 (en) 1986-11-30
SU1480766A3 (ru) 1989-05-15
USRE34672E (en) 1994-07-26
EP0212537A1 (de) 1987-03-04
US4743693A (en) 1988-05-10
FI863305L (fi) 1987-02-18
DE3529529C2 (cs) 1987-05-27
HK59994A (en) 1994-07-08
HU195778B (en) 1988-07-28
DK385586A (da) 1987-02-18
IE862179L (en) 1987-02-17
AU6105586A (en) 1987-02-19
DK162518C (da) 1992-03-30
DE3529529A1 (de) 1987-02-19
UA7080A1 (uk) 1995-06-30
DK385586D0 (da) 1986-08-13
GR862139B (en) 1986-12-30
HUT42069A (en) 1987-06-29
FI863305A0 (fi) 1986-08-15
DE3667970D1 (de) 1990-02-08
US4822807A (en) 1989-04-18
PT83186B (pt) 1988-07-01
ZA866151B (en) 1987-04-29
EP0212537B1 (de) 1990-01-03
FI82189B (fi) 1990-10-31
CS594586A2 (en) 1988-03-15
JPH02191255A (ja) 1990-07-27
PL146086B1 (en) 1988-12-31
NO863305D0 (no) 1986-08-15
PL261052A1 (en) 1987-11-02
KR930009818B1 (ko) 1993-10-11
KR870002076A (ko) 1987-03-30
LTIP898A (en) 1995-03-27
NO863305L (no) 1987-02-18
NZ217172A (en) 1989-02-24
DK162518B (da) 1991-11-11
DD259858A5 (de) 1988-09-07
JPS6245576A (ja) 1987-02-27
CS259891B2 (en) 1988-11-15
CA1307277C (en) 1992-09-08
FI82189C (fi) 1991-02-11
NO170079C (no) 1992-09-09
IE59237B1 (en) 1994-01-26
JPH0415205B2 (cs) 1992-03-17
IL79672A (en) 1990-01-18
LT3596B (en) 1995-12-27
JPH0643400B2 (ja) 1994-06-08
PT83186A (de) 1986-09-01
ES2001522A6 (es) 1988-06-01
AU573454B2 (en) 1988-06-09
USRE34580E (en) 1994-04-05

Similar Documents

Publication Publication Date Title
ZA868249B (en) Pharmaceutical preparation
CS419991A3 (en) Pharmaceutical preparations
GB8421706D0 (en) Pharmaceutical preparations
EP0207451A3 (en) Pharmaceutical preparations
GB8607817D0 (en) Drug preparation
IL75921A0 (en) Gelatinous pharmaceutical preparations
GB8500310D0 (en) Pharmaceutical preparation
GB8623389D0 (en) Pharmaceutical formulations
GB2174004B (en) Pharmaceutical tablet preparations
ZA852279B (en) Pharmaceutical preparations
GB8520189D0 (en) Pharmaceutical preparations
GB8719375D0 (en) Pharmaceutical preparations
GB2171305B (en) Pharmaceutical combinations
GB8506388D0 (en) Pharmaceutical preparations
ZA864716B (en) Pharmaceutical preparations
ZA875281B (en) Zylometzoline-containing pharmaceutical preparations
GB8603031D0 (en) Pharmaceutical formulations
GB8422504D0 (en) Pharmaceutical preparations
GB8522761D0 (en) Pharmaceutical preparation
ZA879119B (en) Pharmaceutical preparations
GB8603271D0 (en) Pharmaceutical preparations
IE861311L (en) Pharmaceutical preparations
GB8630926D0 (en) Pharmaceutical preparations
GB8509942D0 (en) Injectable pharmaceutical preparations
GB8524653D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic